You are here:
Fighting HER2 + Breast Cancer with innovation and hope
PHESGO – the world's first fixed dose combination of two monoclonal antibodies in Oncology for the treatment of HER-2 positive breast cancer now available in India
Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.
Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19
Medical experts view the SEC recommendation for Tecentriq for metastatic urothelial cancer as a promising development for cancer patients in the country.
PINK Project: Fostering early detection to reduce breast cancer burden in the society.
Partnering with DSCI to strengthen the Cancer Care ecosystem in Delhi
For media enquiries, please contact:
Email: [email protected]
